Bfsg, LLC Novartis Ag Transaction History

Bfsg, LLC

$802 Million
Q1 2025

A detailed history of Bfsg, LLC transactions in Novartis Ag stock. As of the latest transaction made, Bfsg, LLC holds 683 shares of NVS stock, worth $75,717. This represents 0.01% of its overall portfolio holdings.

Number of Shares

683

Previous 670 1.94%

Holding current value

$75,717

Previous $65,000 16.92%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 17, 2025	BUY	$97.14 - $115.57 $1,262 - $1,502	13 Added 1.94%	683 $76,000
Q4 2024 Jan 31, 2025	SELL	$96.78 - $117.18 $31,937 - $38,669	-330 Reduced 33.0%	670 $65,000
Q3 2024 Oct 16, 2024	SELL	$106.13 - $120.89 $1,273 - $1,450	-12 Reduced 1.19%	1,000 $115,000
Q2 2024 Jul 29, 2024	BUY	$92.57 - $107.37 $925 - $1,073	10 Added 1.0%	1,012 $107,000
Q1 2024 Apr 23, 2024	BUY	$95.27 - $108.47 $3,810 - $4,338	40 Added 4.16%	1,002 $96,000
Q4 2023 Feb 01, 2024	BUY	$92.27 - $101.54 $88,763 - $97,681	962 New	962 $97,000
Q1 2022 May 04, 2022	SELL	$80.11 - $90.62 $231,117 - $261,438	-2,885 Closed	0 $0
Q4 2021 Jan 24, 2022	SELL	$79.7 - $88.13 $84,083 - $92,977	-1,055 Reduced 26.78%	2,885 $252,000
Q3 2021 Nov 03, 2021	BUY	$81.78 - $95.14 $322,213 - $374,851	3,940 New	3,940 $322,000
Q2 2021 Jul 29, 2021	SELL	$85.24 - $94.15 $420,233 - $464,159	-4,930 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$83.5 - $98.47 $258,015 - $304,272	-3,090 Reduced 38.53%	4,930 $421,000
Q4 2020 Jan 26, 2021	BUY	$78.07 - $94.43 $17,565 - $21,246	225 Added 2.89%	8,020 $757,000
Q3 2020 Nov 04, 2020	BUY	$82.14 - $91.0 $67,354 - $74,620	820 Added 11.76%	7,795 $678,000
Q2 2020 Jul 22, 2020	SELL	$80.93 - $91.1 $26,706 - $30,062	-330 Reduced 4.52%	6,975 $609,000
Q1 2020 Apr 27, 2020	SELL	$70.67 - $99.01 $10,600 - $14,851	-150 Reduced 2.01%	7,305 $602,000
Q4 2019 Jan 29, 2020	SELL	$84.35 - $95.37 $8,435 - $9,537	-100 Reduced 1.32%	7,455 $706,000
Q3 2019 Oct 25, 2019	BUY	$85.54 - $94.26 $56,456 - $62,211	660 Added 9.57%	7,555 $655,000
Q2 2019 Jul 30, 2019	BUY	$75.4 - $92.8 $100,809 - $124,073	1,337 Added 24.06%	6,895 $630,000
Q4 2018 Jan 24, 2019	SELL	$73.66 - $82.02 $7,366 - $8,202	-100 Reduced 1.77%	5,558 $477,000
Q3 2018 Oct 18, 2018	SELL	$66.94 - $77.43 $52,547 - $60,782	-785 Reduced 12.18%	5,658 $487,000
Q2 2018 Jul 31, 2018	BUY	$64.91 - $73.36 $4,738 - $5,355	73 Added 1.15%	6,443 $487,000
Q1 2018 May 08, 2018	SELL	$70.39 - $84.15 $7,039 - $8,415	-100 Reduced 1.55%	6,370 $515,000
Q4 2017 Jan 23, 2018	BUY	$72.33 - $77.64 $52,800 - $56,677	730 Added 12.72%	6,470 $543,000
Q3 2017 Oct 12, 2017	BUY	$74.14 - $77.27 $31,509 - $32,839	425 Added 8.0%	5,740 $493,000
Q2 2017 Aug 10, 2017	BUY	N/A	5,315	5,315 $444,000

Others Institutions Holding NVS

# of Institutions

1,493

Shares Held

131M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $238B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bfsg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bfsg, LLC with notifications on news.

Account